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Abstract
Purpose: To determine the effect of Ultraviolet-A collagen cross-linking with hypo-osmolar and iso-osmolar riboflavin
solutions on stromal collagen ultrastructure in normal and keratoconus ex vivo human corneas.
Methods: Using small-angle X-ray scattering, measurements of collagen D-periodicity, fibril diameter and interfibrillar
spacing were made at 1 mm intervals across six normal post-mortem corneas (two above physiological hydration (swollen)
and four below (unswollen)) and two post-transplant keratoconus corneal buttons (one swollen; one unswollen), before and
after hypo-osmolar cross-linking. The same parameters were measured in three other unswollen normal corneas before and
after iso-osmolar cross-linking and in three pairs of swollen normal corneas, in which only the left was cross-linked (with iso-
osmolar riboflavin).
Results: Hypo-osmolar cross-linking resulted in an increase in corneal hydration in all corneas. In the keratoconus corneas
and unswollen normal corneas, this was accompanied by an increase in collagen interfibrillar spacing (p,0.001); an increase
in fibril diameter was also seen in two out of four unswollen normal corneas and one unswollen keratoconus cornea
(p,0.001). Iso-osmolar cross-linking resulted in a decrease in tissue hydration in the swollen normal corneas only. Although
there was no consistent treatment-induced change in hydration in the unswollen normal samples, iso-osmolar cross-linking
of these corneas did result in a compaction of collagen fibrils and a reduced fibril diameter (p,0.001); these changes were
not seen in the swollen normal corneas. Collagen D-periodicity was not affected by either treatment.
Conclusion: The observed structural changes following Ultraviolet-A cross-linking with hypo-osmolar or iso-osmolar
riboflavin solutions are more likely a consequence of treatment-induced changes in tissue hydration rather than cross-
linking.
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Introduction
Corneal collagen cross-linking therapy is a technique that uses a
combination of riboflavin (vitamin B2) and ultraviolet-A light
(UVA) to induce cross-linking in stromal collagen and thereby
treat corneal ectasia occurring in keratoconus [1,2,3] or following
laser refractive surgery [4,5,6]. It is thought to work by enhancing
the biomechanical properties of the tissue [7,8] and its resistance to
enzymatic digestion [9]. The photosensitiser riboflavin is applied
to the de-epithelialised surface of the cornea and allowed to pene-
trate into the corneal stroma [10,11]. The subsequent exposure of
the cornea to UVA light is thought to result in photodynamic
cross-linking when the riboflavin, excited by UVA, creates free
radicals leading to cross-linking of collagen [11]. Until recently,
this treatment was deemed unsuitable for corneas with a stromal
thickness of less than 400 mm due to the potential for damage to
the endothelium and deeper ocular structures [11]. However, a
recent modification to the technique in which the standard iso-
osmolar riboflavin solution (containing dextran) is substituted with
a hypo-osmolar riboflavin solution (without dextran) to induce
stromal swelling and increase stromal thickness prior to cross-
linking, has enabled the treatment to be performed on very thin
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keratoconus corneas (,400 mm) that would not have previously
been eligible for riboflavin/UVA treatment [12].
Despite the increasing popularity of the approach, little is
known about the specific nature of the cross-links that are formed
as a result of riboflavin/UVA cross-linking, or about their location
either within collagen fibrils or in the interfibrillar matrix. In
principle, many of the results obtained to date could be explained
by assuming cross-links occur at the surface of the collagen fibrils
or between the fibrils and the proteoglycan-rich extrafibrillar
matrix. Small-angle X-ray scattering is a non-invasive technique
that provides information about the axial structure and diameter
of collagen fibrils, as well as the distance by which neighbouring
fibrils are separated from each other within the corneal stroma
[13]. The data obtained are averages from every collagen fibril in
the thickness of the cornea through which the X-rays pass, and are
thus highly representative of the tissue as a whole.
In this study small-angle X-ray scattering was employed to
examine the structural changes that occur within the stroma of
normal and keratoconus corneas following UVA collagen cross-
linking therapy using hypo-osmolar and iso-osmolar riboflavin
solutions.
Methods
Ethics statement
The research presented in this manuscript was approved by the
Human Science Ethical Committee (School of Optometry and
Vision Sciences, Cardiff University, UK) and the South East
Wales Research Ethics Committee (Cardiff, UK). The institutional
review board approved the use of all corneas described in this
study; a waiver of consent was given for the fifteen donor cormeas,
as these were obtained from the Bristol eye bank. All tissue used in
this study was obtained in accordance with the tenets of the
Declaration of Helsinki, and local ethical rules were adhered to
throughout.
Tissue
Two keratoconus corneal buttons (one from a patient aged 24;
one unknown) were obtained with written patient consent from the
Royal Glamorgan Eye Hospital (Llantrisant, UK) following
penetrating keratoplasty. Cornea K1 (8 mm button) had a stellate
scar in the anterior stroma and a scar across the centre of the
cornea at the level of Descemet’s membrane. Cornea K2 (7.5 mm
button) showed slight superficial scarring. Both corneas were less
than 400 mm thick.
In addition, fifteen normal donor corneas, ranging from 61 to
87 years in age, were obtained from the Corneal Transplant
Service (Bristol Eye Bank, UK). Nine of the corneas (N1–9) were
single specimens from individual donors but six of the corneas
(N10+N11, N12+N13, N14+N15) were left/right pairs from the
same donor. The normal corneas, which were deemed unsuitable
for transplantation surgery due to a low endothelial cell count, had
been stored in culture medium (minimum essential medium+2%
fetal calf serum) for several weeks and thus presented a range of
above physiological tissue hydrations. On receipt, both keratoco-
nus corneal buttons (K1–2) and two of the normal corneas (N5–6)
were wrapped tightly in ClingfilmTM (Superdrug Stores, Croydon,
UK) to prevent tissue dehydration and stored at 280uC until
required for experimentation. The remaining normal corneas
(N1–4 and N7–N15) were not frozen at any stage.
Prior to data collection, the frozen corneas (K1–2 and N5–6)
were thawed at room temperature. Seven of the normal corneas
(N1–4 and N7–9) were air dried to near physiological hydration
prior to data collection and cross-linking. During the air drying
process, pachymetry was used to monitor corneal thickness every
5 minutes; air drying was terminated when a tissue thickness of
500–550 microns was reached and the tissue deemed to be
‘unswollen’. The cornea was then weighed and wrapped tightly in
clingfilm to prevent further drying during data collection. The
remaining normal corneas (N5–6 and N10–N15) were examined
using X-rays and, in the case of N5–N6, N10, N12 and N14 were
also cross-linked, whilst they were still swollen.
Due to the sensitivity of collagen interfibrillar spacing to
changes in corneal hydration [14] it was necessary to calculate
tissue hydration pre and post cross-linking. This was done using
the equation: Hydration= (wet weight-dry weight)/dry weight. As
the pre-treatment hydration varied between corneas at the start of
the study (H= 1.9 to 6.6), owing to conditions of storage and
handling, they have been classified as being swollen (above a
physiological hydration of H=3.2) or unswollen (at or below
H=3.2). Sample details and classification have been summarised
in Table 1.
Iso-osmolar/Hypo-osmolar riboflavin/UVA cross-linking
The iso-osmolar cross-linking treatment used throughout this
study involved the removal of the corneal epithelium followed by a
single application of iso-osmolar riboflavin eye drops (containing
riboflavin 0.136% and dextran 20%). After five minutes, the
cornea was then exposed to a 30 minute 3.04 mW/cm2 dose of
Table 1. Sample details and treatments.
Sample Hydration Classification
Riboflavin/UVA
treatment
Hypo-osmolar riboflavin/UVA cross-linking: Keratoconus
K1 2.2 Keratoconus; unswollen Hypo-osmolar
K2 3.8 Keratoconus; swollen Hypo-osmolar
Hypo-osmolar riboflavin/UVA cross-linking: Normal
N1 2.3 Normal; unswollen Hypo-osmolar
N2 2.4 Normal; unswollen Hypo-osmolar
N3 2.1 Normal; unswollen Hypo-osmolar
N4 2.5 Normal; unswollen Hypo-osmolar
N5 6.6 Normal; swollen Hypo-osmolar
N6 6.6 Normal; swollen Hypo-osmolar
Iso-osmolar riboflavin/UVA cross-linking: Normal
N7 2.0 Normal; unswollen Iso-osmolar
N8 1.9 Normal; unswollen Iso-osmolar
N9 2.5 Normal; unswollen Iso-osmolar
N10 5.7* Normal left; swollen Iso-osmolar
N11 5.7 Normal right; swollen None (control for N10)
N12 5.3* Normal left; swollen Iso-osmolar
N13 5.3 Normal right; swollen None (control for N12)
N14 5.2* Normal left; swollen Iso-osmolar
N15 5.2 Normal right; swollen None (control for N14)
Details of pre-treatment tissue hydration (recorded at the time of
data collection), classification and UVA cross-linking treatment (hypo-
osmolar/iso-osmolar riboflavin solution) are shown for each sample.
Each cornea has been classified as being either ‘unswollen’ (at or
below a physiological hydration of H=3.2) or ‘swollen’ (above
physiological hydration).
*The pre-treatment hydration of samples N10, N12 and N14 was
assumed to be the same as that of their untreated pair (N11, N13 and
N15 respectively).
doi:10.1371/journal.pone.0022405.t001
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UVA, during which time the iso-osmolar riboflavin eye drops were
re-applied at 3 minute intervals. In the case of hypo-osmolar
riboflavin cross-linking, the iso-osmolar riboflavin eye drops
were replaced with hypo-osmolar eye drops (containing riboflavin
0.136%, but no dextran).
Small-angle X-ray scattering data collection and analysis
The corneas (wrapped in Clingfilm) were mounted in a sealed
polymethyl methacrylate (Perspex; theplasticshop.co.uk, Coventry,
UK) chamber with polyester film (Mylar; DuPont-Teijin, Mid-
dlesbrough, UK) windows and positioned ready for X-ray scat-
tering data collection on Station I22 at the Diamond Light Source
(Didcot, UK).
Small-angle X-ray scattering patterns were obtained at 1 mm
intervals (in a grid) over two keratoconus corneal buttons (K1 and
K2), four unswollen normal corneas (N1–4) and two swollen
normal corneas (N5 and N6). The corneas were then cross-linked
using UVA and a hypo-osmolar riboflavin solution and X-ray
scatter patterns again collected at 1 mm intervals over each
sample. In the same way, X-ray scatter patterns were obtained
from three normal unswollen corneas (N7–N9) before and after
iso-osmolar cross-linking. Each X-ray scatter pattern resulted from
a 10 s exposure to a 0.1 nm wavelength X-ray beam focussed to
measure 0.260.2 mm at the specimen. The data were recorded on
a detector positioned 5 m (N1–N4 and N7–N9) or 6 m (N5, N6,
K1 and K2) behind the specimen. Also examined were three pairs
of swollen corneas (N10+N11, N12+N13, N14+N15) in which the
left of each pair was cross-linked with iso-osmolar riboflavin
solution and UVA and the right served as an untreated control. A
single X-ray scatter pattern was collected from the centre of each
treated and untreated cornea using an X-ray beam focussed to
measure 0.5 mm vertically by 2 mm horizontally.
Each X-ray scatter pattern consisted of an intense equatorial
reflection, arising from the regular short-range spacing of collagen
fibrils, a fainter and broader subsidiary equatorial maxima, caused
by the uniformity of fibril diameters, and a series of sharp meridional
reflections arising from the axial periodicity (D-period) along the
fibrils. The X-ray scatter patterns were calibrated against the 67 nm
meridional spacing of collagen in hydrated rat tail tendon.
Measurements of collagen D-period, fibril diameter and inter-
fibrillar Bragg spacing before and after treatment at each mea-
sured position in the cornea were determined from the calibrated
positions of the meridional [13], subsidiary equatorial maxima
[13,15,16] and innermost equatorial reflection [13,16], respec-
tively. The relationship between X-ray Bragg spacing and the
corresponding centre-to-centre distance of the parameter under
investigation depends on the precise packing of the fibrils within
the stroma. Most previous investigations have assumed a liquid-
like or quasi-hexagonal packing [15,17], in which case Bragg
spacings need to be multiplied by a factor of 1.12 in order to
convert to centre-to-centre spacings. However, as we are only
concerned here with changes in these parameters, we present all
results as Bragg spacings.
A paired student t-test was used to statistically examine differences
between cross-linked and non-crosslinked specimens in terms of
collagen fibril diameter, interfibrillar spacing and D-periodicity.
Based on the accuracy with which measurements of the various
collagen parameters could be made, a probability of P,0.001 was
taken to indicate a statistically significant treatment difference.
Results
Table 2 summarises the changes in hydration, collagen fibril
diameter, interfibrillar spacing and D-periodicity in normal and
keratoconus corneas following iso-osmolar and hypo-osmolar
riboflavin/UVA collagen cross-linking. The contents of the table
are discussed below.
Hypo-osmolar riboflavin/UVA cross-linking of
keratoconus corneas
Tissue hydration increased in both keratoconus corneas
following hypo-osmolar riboflavin/UVA cross-linking. In each
case, this was accompanied by an increase in collagen interfibrillar
spacing (p,0.001) (Figure 1).
In the unswollen cornea (K1), an increase in fibril diameter was
observed following hypo-osmolar riboflavin/UVA cross-linking
(p,0.001) (Figure 2) but in the swollen cornea (K2) fibril diameter
appeared to be unaffected by the same treatment. Interestingly,
the region of highest pre-treatment fibril diameter in sample K1
coincided with the site of the stellate scar in the anterior stroma
and the scar across the centre of the cornea at the level of
Descemet’s membrane (as recorded schematically by the operating
surgeon prior to performing penetrating keratoplasty). The scarred
region also showed the greatest percentage change (12–14%
increase) in fibril diameter following treatment (Figure 2).
The D-periodicity of corneal collagen in keratoconus corneas
did not change following hypo- osmolar riboflavin/UVA collagen
cross-linking treatment.
Hypo-osmolar riboflavin/UVA cross-linking of normal
corneas
Hypo-osmolar riboflavin/UVA cross-linking resulted in an
increased tissue hydration in all normal corneas, and a significant
increase in collagen interfibrillar spacing in the unswollen corneas
(N1–N4) (p,0.001) (Figure 1).
Fibril diameter increased significantly following hypo-osmolar
riboflavin/UVA cross-linking treatment in two (N1 and N4) out of
four unswollen corneas (p,0.001) (Figure 2). In the remaining
unswollen (N2 and N3) and swollen (N5 and N6) corneas, no
treatment-induced change in fibril diameter was detected.
Collagen D-periodicity did not change as a result of hypo-
osmolar riboflavin/UVA collagen cross-linking treatment in normal
corneas.
Iso-osmolar riboflavin/UVA cross-linking of normal corneas
There was no consistent change in tissue hydration following
iso-osmolar riboflavin/UVA cross-linking of unswollen corneas
(N7–N9). However, in each pair of swollen corneas, tissue hydra-
tion was always lower in the treated cornea (N10, N12, N14)
compared to its untreated control (N11, N13, N15).
As shown in Table 1 and Figure 1, iso-osmolar riboflavin/UVA
cross-linking resulted in a significant decrease in collagen interfi-
brillar spacing in the unswollen corneas (N7–N9) (p,0.001).
Interfibrillar spacing was also lower in the treated cornea (N10,
N12, N14) of each pair of swollen corneas compared to its
untreated partner (N11, N13, N15), however this difference was
found to be non-significant. The lack of significance in this case
may be due to the fact that only one measurement was recorded
from the centre of the treated/untreated paired corneas (N10–
N15), whereas the statistics for each unswollen cornea (N7–N9)
were calculated from a much larger number of data points (.50)
recorded before and after treatment.
Iso-osmolar riboflavin/UVA cross-linking caused a significant
decrease in fibril diameter in all unswollen corneas (N7–N9)
(p,0.001) (Figure 2), but no difference in the average diameter of
collagen fibrils was detected between the treated and untreated
pairs of swollen corneas (N10–N15).
Riboflavin/UVA Collagen Cross-Linkage
PLoS ONE | www.plosone.org 3 August 2011 | Volume 6 | Issue 8 | e22405
The D-periodicity of corneal collagen did not change following
iso- osmolar riboflavin/UVA collagen cross-linking treatment.
Discussion
Previous X-ray scattering experiments have shown that as the
cornea ages (birth to 90 years), cross-linking leads to a 14%
increase in the cross-sectional area associated with each molecule
within a fibril [18]. It has also been shown that, in vitro, the
formation of advanced glycation end-products can cause increases
in intermolecular spacing of up to 50% [19,20]. Measurements of
fibril diameter may, therefore, be a useful indicator of the
occurrence of collagen cross-linking in a tissue at the molecular
level.
In a previous preliminary abstract on porcine corneas cross-
linked using iso-osmolar riboflavin solution and UVA [21], we
reported that cross-linking increased the intermolecular spacing.
However, further investigations revealed that the apparent
increase was an artefact, and was not due to the cross-linking (S
Hayes, CS Kamma-Lorger, C Boote and KM Meek – unpub-
lished data). In this study, no direct structural changes attributable
to cross-linkage were found; fibril diameters were seen to increase
only when hypo-osmolar conditions were used and only when the
cornea was below physiological hydration prior to treatment. This
suggests that increases in fibril diameter under these conditions are
due to tissue swelling rather than to molecules being pushed
further apart by newly formed inter-molecular cross-links. This
finding is in agreement with our recent studies examining the
change in collagen inter-molecular spacing of iso-osmolar
riboflavin/UVA cross-linked pig corneas during the drying process
(from H=2.7 to H=0), in which it was observed that the
reduction in intermolecular spacing was the same in both treated
and untreated corneas at all levels of hydration (unpublished).
Since the inter-molecular spacing of corneal collagen is known to
increase as the hydration of the tissue increases from dry (H= 0) to
physiological (H=3.2) [14] but remains fairly stable thereafter
[14,22], it may be presumed that in swollen corneas, the absence
of any cross-linking-induced changes in fibril diameter is due to the
covalent cross-links between adjacent collagen molecules already
being at their maximum extension prior to treatment. The fact that
the largest diameter increase corresponded to the scarred region of
one keratoconus button suggests that the scar tissue might contain
collagen fibrils with less naturally occurring cross-links, which are
thus able to swell more than the other collagen fibrils in that
particular cornea. Indeed, corneal wound healing studies in rabbits
have shown the presence of abnormal collagen intermolecular cross-
linking in scar tissue even after a year of healing [23]. We therefore
were unable to confirm the observations of a previous electron
microscopy study which showed evidence of larger than normal
fibrils after iso-osmolar cross-linking treatment in both the anterior,
and to a lesser extent the posterior, of the rabbit cornea [24].
However, several possible explanations exist for the difference in the
outcomes of these studies. The first is that species differences in the
response of the cornea to cross-linking may exist due to variations in
stromal thickness and hence the proportion of the cornea that
is cross-linked; as only the anterior 300 microns of the tissue is
Table 2. Tissue hydration and collagen parameters measured before (CXL-) and after (CXL+) riboflavin/UVA collagen cross-linking.
Sample Hydration Fibril Diameter (nm) Interfibrillar Spacing (nm) D-period (nm)
CXL2 CXL+ CXL2 CXL+ CXL2 CXL+ CXL2 CXL+
Hypo-osmolar riboflavin/UVA cross-linking: Keratoconus
K1 2.2 4.0 31.1 (0.1) 32.8 (0.1) 38.3 (0.3) 47.3 (0.2) 65.4 (0.1) 65.5 (0.1)
K2 3.8 6.0 31.6 (0.1) 32.0 (0.2) 49.7 (0.3) 61.2 (0.4) 65.5 (0.1) 65.4 (0.1)
Hypo-osmolar riboflavin/UVA cross-linking: Normal
N1 2.3 3.5 34.5 (0.1) 34.8 (0.1) 48.1 (0.1) 51.1 (0.2) 65.2 (0.1) 65.2 (0.1)
N2 2.4 4.1 32.9 (0.3) 32.7 (0.2) 48.2 (0.2) 52.6 (0.2) 66.1 (0.1) 66.1 (0.1)
N3 2.1 2.9 34.3 (0.1) 34.6 (0.1) 50.5 (0.1) 52.6 (0.2) 65.2 (0.1) 65.2 (0.1)
N4 2.5 3.4 33.4 (0.1) 33.8 (0.1) 50.7 (0.3) 54.2 (0.3) 66.1 (0.1) 66.1 (0.1)
N5 6.6 6.9 33.8 (0.2) 33.5 (0.1) 58.6 (0.4) 60.2 (0.3) 64.7 (0.1) 64.5 (0.1)
N6 6.6 6.8 33.2 (0.2) 33.8 (0.4) 57.9 (0.3) 57.2 (0.3) 63.7 (0.1) 63.5 (0.1)
Iso-osmolar riboflavin/UVA cross-linking: Normal
N7 2.0 2.2 33.6 (0.1) 31.0 (0.1) 50.0 (0.1) 39.2 (0.1) 66.1 (0.1) 66.1 (0.1)
N8 1.9 1.8 33.5 (0.1) 32.4 (0.1) 49.2 (0.3) 44.9 (0.3) 65.2 (0.1) 65.2 (0.1)
N9 2.5 2.7 34.0 (0.1) 31.9 (0.1) 49.1 (0.2) 41.6 (0.3) 65.2 (0.1) 65.2 (0.1)
N10 - 5.4 - 33.1 - 46.5 - 66.0
N11 5.7 - 33.7 - 49.1 - 66.0 -
N12 - 5.1 - 33.3 - 48.5 - 66.0
N13 5.3 - 32.1 - 49.1 - 66.0 -
N14 - 4.7 - 33.3 - 50.4 - 66.0
N15 5.2 - 33.7 - 51.0 - 66.0 -
Average values (+/2 SEM) of collagen parameters for all samples (excluding N10–N15) were calculated using.50 measurements recorded from the
central 8 mm region of the same corneas before (CXL2) and after cross-linking (CXL+). Averaged data shown for samples N10–N15 (3 pairs of
corneas in which the left of each pair (N10, N12 and N14) was cross-linked (CXL+) and the right (N11, N13 and N15) remained untreated (CXL2)) is
based on a single measurements obtained from the centre of each cornea. Bold type is used to indicate pre and post treatment differences in
collagen parameters at p,0.001.
doi:10.1371/journal.pone.0022405.t002
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cross-linked [25] this represents approximately 75% of the rabbit
cornea and 55% of the physiologically hydrated human cornea. The
proportion of cross-linked human cornea reduces to 35% when the
tissue is swollen, based on a calculated corneal thickness of 851 mm
at a hydration of H=6.6 [26]. Secondly, small changes in fibril
diameter which are limited to the anterior cornea may be masked by
averaging measurements throughout the full thickness of the tissue
as has been done here. Another possibility is that the age of the
corneas may affect the efficacy of the cross-linking process. The
normal corneas used in this study were from older patients, whose
collagen was likely already naturally cross-linked due to ageing;
these patients would therefore have had a higher inter-molecular
spacing of collagen and a larger fibril diameter than that of younger
individuals, [18,22] even before UVA cross-linking.
The absence of any detectable changes between riboflavin/
UVA treated and untreated corneas in terms of the D-period of
the collagen, when measured as an average throughout the entire
thickness of the tissue, leads us to conclude that UVA/riboflavin
induced cross-links do not have any measurable effect on the axial
stagger or the tilt of the collagen molecules within the fibrils. This
is not wholly surprising because it seems that D-spacing is rather
insensitive to cross-linking, as even with strong fixative such as
glutaraldehyde it only shrinks by less that 0.8% [27]. Additionally,
the data presented here confirms the findings of Daxer et al. [22]
which showed that at hydrations above H=2.5, collagen D-
periodicity is independent of changes in tissue hydration.
On average, the interfibrillar spacing decreased after iso-osmolar
riboflavin/UVA treatment, due to the presence of dextran which
acts as a deturgescent. This finding supports our previous data from
pig corneas following similar treatment [21]. As fibrils approach
each other, ordering would be expected to increase and this is
consistent with the reported increase in transparency of hen corneas
following iso-osmolar riboflavin/UVA collagen cross-linking [28].
Two of the normal human corneas incubated with hypo-osmolar
riboflavin/UVA were quite swollen before the treatment and
therefore showed only a modest increase or no change in the
interfibrillar spacing. In the unswollen normal and keratoconus
corneas, however, interfibrillar spacing increased significantly after
hypo-osmolar riboflavin/UVA treatment.
Hypo-osmolar riboflavin solutions have been suggested as a
means of swelling thin keratoconus corneas to allow riboflavin/
UVA cross-linking without risking damage to the endothelial cells
[12]. Corneal thickness was reported to increase by up to 30%
after this treatment and there seemed to be no damage to the
endothelium. However, it is well known that when the cornea
swells, water can enter different compartments, and these can be
between lamellae, into voids or ‘‘lakes’’ within lamellae, between
the fibrils within the lamellae or within the fibrils themselves
[14,29,30,31]. Here we have shown that, although some fluid
enters the fibrils, the majority of the swelling occurs between the
fibrils. For example, average interfibrillar spacing increases by up
to 30% (Fig. 1, K2) following hypo-osmolar riboflavin swelling,
which is similar to the increase in overall tissue thickness. This
suggests that swelling is primarily intra-lamellar and occurs
Figure 1. Changes in collagen interfibrillar spacing following
Riboflavin/UVA cross-linking. The contour maps show collagen
interfibrillar spacing (IFS) in an unswollen normal cornea (N3) and a
slightly swollen keratoconus cornea (K2) before and after hypo-osmolar
riboflavin/UVA cross-linking (Hypo-R CXL) and a normal unswollen
cornea (N8) before and after iso-osmolar riboflavin/UVA cross-linking
(Iso-R CXL). The centre of each corneal button corresponds approxi-
mately with the centre of each map.
doi:10.1371/journal.pone.0022405.g001
Figure 2. Changes in collagen fibril diameter following
Riboflavin/UVA cross-linking. The contour maps show collagen
fibril diameter in an unswollen normal (N1) and keratoconus (K1) cornea
before and after hypo-osmolar riboflavin/UVA collagen cross-linking
(Hypo-R CXL) and an unswollen normal cornea (N7) before and after iso-
osmolar riboflavin/UVA collagen cross-linking (Iso-R CXL). The centre of
each corneal button corresponds approximately with the centre of each
map. The locations of the stellate scar (solid line) and the scar at
Descemet’s membrane level (broken line) (as recorded schematically by
the operating surgeon) have been superimposed onto the contour
maps of K1.
doi:10.1371/journal.pone.0022405.g002
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between the collagen fibrils. However, this swelling has the effect
of thinning the effective thickness of the protective riboflavin film,
and it was shown that a hypo-osmolar riboflavin solution film has
lower viscocity and a lower absorption coefficient for UVA
radiation than iso-osmolar riboflavin, and becomes unstable after
only 90 seconds [32], so would need to be used with caution in a
clinical setting.
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